Related Experiment Video

Updated: Jun 24, 2025

A Caenorhabditis elegans Model System for Amylopathy Study
10:33

A Caenorhabditis elegans Model System for Amylopathy Study

Published on: May 17, 2013

10.5K

Iminosugar-Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers

Maria Giulia Davighi1, Francesca Clemente1, Emilie Sperling Andreasen2

  • 1Department of Chemistry "U. Schiff", University of Florence, via della Lastruccia 3-13, 50019, Sesto F.no (FI), Italy.

Chemistry & Biodiversity
|June 7, 2024
PubMed

Keywords:
Click chemistryEnzyme modulatorsGaucher diseaseNeuronopathic disorderPhotochromism

More Related Videos

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase11:01

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase

Published on: November 23, 2016

9.7K
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.1K

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181